Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PFSA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsProfusa draws on equity line with 9.99% dilution cap and downside price protection
Filed June 8, 2026 · Period ending June 8, 2026 · ~1 min read
Key Changes
-
high
Company requested share sale to Ascent Partners under existing equity line, allowing drawdown up to 9.99% of shares outstanding (capped at $200,000) through July 15, 2026—a significant potential dilution event.
Item 1.01 view on EDGAR → -
high
Modified pricing gives Company 97% of lowest 10-day trailing VWAP upfront, but includes True-Up Mechanism requiring additional share issuance if stock falls while Ascent sells—creating compounding dilution risk.
Item 1.01 view on EDGAR → -
medium
Terms represent temporary modification of July 2025 equity line (amended December 2025), providing faster cash access but at 3% discount and with downside protection favoring investor over shareholders.
Item 1.01 view on EDGAR →
Summary
Profusa activated its equity line of credit with Ascent Partners, requesting a share sale under modified terms that run through mid-July 2026. The Company can draw up to 9.99% of outstanding shares per advance notice (capped at $200,000), receiving 97% of the lowest 10-day volume-weighted average price upfront rather than waiting for Ascent to sell the shares.
While this accelerates cash receipt, it comes at a 3% discount and includes a concerning True-Up Mechanism that requires issuing additional shares if the stock price declines while Ascent is selling—effectively guaranteeing Ascent's return at shareholders' expense. Retail investors should understand this creates immediate and potentially compounding dilution.
The 9.99% cap per notice is substantial, and the True-Up provision means actual dilution could exceed initial estimates if selling pressure drives the price down. This financing structure suggests the Company needs capital quickly and is willing to accept dilutive terms to get it. Watch for the actual number of shares issued in subsequent filings and any additional advance notices before the July 15 expiration of these modified terms.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Company issued Advance Notice to Ascent Partners to purchase up to 9.99% of shares outstanding under equity line of credit with modified pricing terms.
Added in current filing · verify on EDGAR →
On June 8, 2026, Profusa, Inc. (the “Company”) submitted an Advance Notice to Ascent Partners Fund LLC (“Ascent”) requesting that Ascent purchase shares of the Company’s common stock under the equity line of credit arrangement between the Company and Ascent set forth in that certain Securities Purchase Agreement, dated as of July 28, 2025 and amended on December 22, 2025 (the “SPA”).
The Company requested a drawdown from its existing equity line of credit with Ascent Partners. This represents an active use of the Company's at-the-market equity financing facility established in July 2025 and previously amended in December 2025.
Added in current filing · verify on EDGAR →
For Advance Notices issued during June 8, 2026 until July 15, 2026 with payment upon share delivery, the Company agreed (i) that the Purchaser shall allow an Advance Notice for up to 9.99% of the shares outstanding at the time of said Advance Notice (subject to a cap of $200,000 per Advance Notice), (ii) that the purchase price for the shares will be funded upon delivery of the shares to Ascent prior to the end of the pricing period, rather than upon Ascent’s subsequent exit or sale of such shares, with Ascent remitting within one trading day 97% of the lowest volume-weighted average price (“VWAP”) of the common stock in the ten trading days prior to the Advance Notice date times the number of shares requested
The Company modified the equity line terms for a limited period (June 8 to July 15, 2026). Key changes include: allowing drawdowns up to 9.99% of outstanding shares (capped at $200,000), receiving payment upfront at 97% of the lowest 10-day trailing VWAP rather than waiting for Ascent to sell the shares, and waiving mandatory prepayment provisions. This provides faster access to capital but at a 3% discount and potentially significant dilution.
Added in current filing · verify on EDGAR →
to include a price adjustment mechanism (the “True-Up Mechanism”) such that if 97% of the lowest VWAP of the common stock during the period starting on the closing date and ending on the date when Ascent has entered into committed, binding trades to sell all of the purchased shares (the “Adjustment Period”) is lower than the closing price, then the Company will issue additional shares to Ascent so that the aggregate number of shares received by Ascent equals the number of shares it would have received if the closing price had been equal to such adjusted price.
The Company agreed to a downside protection mechanism for Ascent. If the stock price declines during the period when Ascent is selling the shares, the Company must issue additional shares to compensate Ascent for the lower realized price. This creates potential for additional dilution beyond the initial share issuance if the stock price falls during Ascent's selling period.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify